Citing insufficient data, Pfizer today said it will delay applying for Emergency Use Authorization of its COVID vaccine for infants and children 6 months to 4 years old.

 

SAMPLE LETTER CLICK HERE 

COPY & PASTE EMAIL ADDRESSES CLICK HERE